TG Therapeutics Inc (TGTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.75B
Last updated: Nov 17, 2026 at 11:06 AM ET
TG Therapeutics Inc (TGTX) Competitors
The companies most similar to TG Therapeutics are Protagonist Therapeutics (PTGX), Spyre Therapeutics (SYRE) and Dianthus Therapeutics (DNTH). TG Therapeutics trades at 87.2x earnings, against a median of 39.6x for the 3 of these companies with a P/E. By market cap, TG Therapeutics ranks 6th of the 13 companies on this page; BridgeBio Pharma (BBIO) is the largest at $15.25B.
Peer Comparison
TGTX's ROIC of 11.0% is above the peer median of -23.1%, and its revenue growth of 60.7% is above the median of 33.2%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| TG Therapeutics (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Spyre Therapeutics Inc. (SYRE) | $9.88B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Dianthus Therapeutics Inc. (DNTH) | $5.17B | N/A | N/A | 0.0% | N/A | 205.6% | 0.00% |
| Summit Therapeutics PLC (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Bio-Techne Corp (TECH) | $11.44B | 39.6x | 9.3x | 14.0% | 7.7% | 4.6% | 0.44% |
| Immunovant Inc (IMVT) | $7.07B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PTC Therapeutics Inc (PTCT) | $5.30B | N/A | 5.2x | -9.2% | 18.1% | 69.6% | 0.00% |
| Apogee Therapeutics, Inc. Common Stock (APGE) | $10.22B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Krystal Biotech Inc (KRYS) | $9.05B | 40.4x | 18.8x | 47.9% | N/A | 30.2% | 0.00% |
| Axsome Therapeutics Inc (AXSM) | $7.45B | N/A | 8.6x | -18.2% | -48.1% | 51.9% | 0.00% |
| Travere Therapeutics Inc (TVTX) | $4.86B | N/A | 7.2x | -18.7% | -23.1% | 36.2% | 0.00% |
| BridgeBio Pharma Inc (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| Peer median | $8.80B | 39.6x | 9.3x | 0.0% | -23.1% | 33.2% | 0.00% |
Similar Companies
These are the 12 companies most similar to TG Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Spyre Therapeutics Inc. (SYRE) | Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by... | SYRE competitors |
| Dianthus Therapeutics Inc. (DNTH) | Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops... | DNTH competitors |
| Summit Therapeutics PLC (SMMT) | Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America... | SMMT competitors |
| Bio-Techne Corp (TECH) | Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments... | TECH competitors |
| Immunovant Inc (IMVT) | Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. | IMVT competitors |
| PTC Therapeutics Inc (PTCT) | PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. | PTCT competitors |
| Apogee Therapeutics, Inc. Common Stock (APGE) | Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)... | |
| Krystal Biotech Inc (KRYS) | Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United... | KRYS competitors |
| Axsome Therapeutics Inc (AXSM) | Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United... | AXSM competitors |
| Travere Therapeutics Inc (TVTX) | Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification... | TVTX competitors |
| BridgeBio Pharma Inc (BBIO) | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. | BBIO competitors |
Frequently Asked Questions About TGTX
Who are TG Therapeutics' main competitors?
The companies most similar to TG Therapeutics include Protagonist Therapeutics (PTGX), Spyre Therapeutics (SYRE), Dianthus Therapeutics (DNTH), Summit Therapeutics (SMMT) and Bio-Techne (TECH), listed from the closest match.
Who is TG Therapeutics' biggest competitor?
BridgeBio Pharma (BBIO) is the largest of the similar companies at $15.25B; Protagonist Therapeutics (PTGX) is the closest match by business profile, size, sector and industry.
How does TGTX stock compare with its competitors?
TGTX's P/E is 87.2x against a peer median of 39.6x; its P/S is 11.1x against a peer median of 9.3x; its net margin is 11.8% against a peer median of 0.0%.
Which of TG Therapeutics' competitors pays a higher dividend?
TG Therapeutics pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.
Is TG Therapeutics bigger than its competitors?
No. TG Therapeutics is 6th by market cap among the 13 companies on this page; the largest is BridgeBio Pharma (BBIO) at $15.25B.
TGTX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors